Merck & Co. Inc. / Microbiological Research Station / Pfizer Inc. (Chas. Pfizer & Co. Inc.)
MS. Abraham 102/C.922-C.943
Bodleian Libraries, University of Oxford
Description
From Bodleian Archives & Manuscripts
This is an extract only. For more information, see the catalogue record in Bodleian Archives & Manuscripts.
Bodleian Archives & Manuscripts contains descriptions of the Bodleian Libraries’ archival collections, including post-1500 manuscripts. Some manuscripts with records in other catalogues are also described here as part of a description of a larger archive. Learn more.
Title
Merck & Co. Inc. / Microbiological Research Station / Pfizer Inc. (Chas. Pfizer & Co. Inc.)
Shelfmark
MS. Abraham 102/C.922-C.943
Summary
C.922-C.928 (Merck & Co. Inc.): Merck was one of the companies licensed by the NRDC in the early 1960s to work on the production of the Cephalosporin C nucleus. Correspondence regarding research on Cephalosporin C and other antibiotics, 1950, 1953, 1958-1981.
C.929-C.940 (Microbiological Research Station, Porton Down): The station supplied microorganisms and microbial products to research workers. In 1961 it began a Cephalosporin C production project to assist with the research programme overseen by the NRDC. Correspondence, with copies of reports, regarding work on Cephalosporin C and B-lactamases, 1948, 1950, 1956-1978, 1992. Mostly 1959-1978.
C.941-C.943 (Chas. Pfizer & Co. Inc.): Pfizer was one of the companies licensed by the NRDC in the early 1960s to work on the production of the Cephalosporin nucleus. Correspondence regarding research on Cephalosporin C and other antibiotics, 1960-1962, 1977, 1978, 1985, 1986. Mostly 1960-1962.
Date
1948-1992
Language
English
Physical extent
22 folders
View full record in Bodleian Archives & Manuscripts
Collection contents
Archive of Sir Edward Penley Abraham
Research
Other organisations
Merck & Co. Inc. / Microbiological Research Station / Pfizer Inc. (Chas. Pfizer & Co. Inc.)
